首页|期刊导航|药物分析学报（英文）|Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Wujun Chen Bing Liang Xiaolin Wu Ling Li Chao Wang Dongming Xing

药物分析学报（英文）2023，Vol.13Issue(3)：255-261,7.

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Wujun Chen ¹Bing Liang ¹Xiaolin Wu ¹Ling Li ²Chao Wang ¹Dongming Xing³

作者信息

1. Cancer Institute||Department of Orthopedics,The Affiliated Hospital of Qingdao University,Qingdao,Shandong,266071,China
2. Qingdao Cancer Institute,Qingdao University,Qingdao,Shandong,266071,China
3. Cancer Institute||Department of Orthopedics,The Affiliated Hospital of Qingdao University,Qingdao,Shandong,266071,China||Department of Pharmacy,The Fifth Affiliated Hospital,Sun Yat-sen University,Zhuhai,Guangdong,519000,China
折叠

摘要

关键词

Nirmatrelvir/Pharmacology/Pharmacokinetics/Toxicology/Derivatives/COVID-19

Key words

Nirmatrelvir/Pharmacology/Pharmacokinetics/Toxicology/Derivatives/COVID-19

引用本文复制引用

Wujun Chen,Bing Liang,Xiaolin Wu,Ling Li,Chao Wang,Dongming Xing..Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection[J].药物分析学报（英文）,2023,13(3):255-261,7.

基金项目

This study was supported by the Qingdao Major Scientific and Technological Project for Distinguished Scholars(Project No.:20170103),the Laoshan Major Scientific and Technological Project for Distinguished Scholars(Project No.:20181030),the Natural Science Foundation of Shandong Province(Project No.:ZR2020MH369),the Hospital Pharmacy Research Foundation of Guangdong Province(Project No.:2022A01),and the Science and Technology Planning Project in Zhuhai(Project No.:ZH2202200090HJL). （Project No.:20170103）

药物分析学报（英文）

OACSCD

ISSN：2095-1779

访问量0

下载量0

段落导航